TIL
Instil Bio is a biotechnology company focused on developing cell therapies for oncology, with a clinical pipeline and strategic collaborations. The company operates in the United States and pursues immunotherapy approaches through research and development programs, including licensing partnerships. It emphasizes patient-centered innovation and has an active investor and corporate partnership presence.
No recent news for this company.
No recent deals for this company.